open access

Online first
Letter to the Editor
Published online: 2021-07-16
Get Citation

Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the “miraculous” sodium-glucose co-transporter-2 inhibitors?

Dimitrios Patoulias, Christodoulos Papadopoulos, George Kassimis, Michael Doumas
DOI: 10.33963/KP.a2021.0067
·
Pubmed: 34292565

open access

Online first
Letter to the Editor
Published online: 2021-07-16

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the “miraculous” sodium-glucose co-transporter-2 inhibitors?

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Letter to the Editor

Published online

2021-07-16

DOI

10.33963/KP.a2021.0067

Pubmed

34292565

Authors

Dimitrios Patoulias
Christodoulos Papadopoulos
George Kassimis
Michael Doumas

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl